Article Type
Audio
Changed
Tue, 08/28/2018 - 11:03
Display Headline
Is it time to rethink the use of oral contraceptives in premenopausal women with migraine?
Author(s)
Anne H. Calhoun, MD

Part 1 Data dissection

  • Migraine versus migraine with aura versus tension headache
  • Baseline risk of stroke in patients with migraine
  • What does the literature suggest about the risk of stroke associated with combination oral contraceptives (OCs) in women with migraine?
  • What have been the objections in the past to OC use in women with migraine?

Part 2 Successful interventions for avoiding menstrual headache

  • How might women with migraine benefit from OCs?
  • Estrogen dose: Does it make a difference in headache avoidance?
  • Is low dose or continuous OC use the best option for contraception in women with migraine?
  • Should an ObGyn consult with a headache specialist before prescribing combination OCs to women with migraine?

Download transcript for Part 1

Download transcript for Part 2

Article PDF
Calhoun_Audio_transcript_Part1.pdf
Author and Disclosure Information

Dr. Calhoun is cofounder of the Carolina Headache Institute and Professor, Departments of Psychiatry and Anesthesiology, University of North Carolina, Chapel Hill.

Dr. Calhoun reports receiving research support from ElectroCore and GlaxoSmithKline, serving as a speaker for Nautilus Neurosciences and Zogenix, and consulting to Allergan, Nautilus, and Zogenix.

Issue
OBG Management - 25(10)
Publications
MDedge ObGyn
OBG Management
Topics
Contraception
Legacy Keywords
migraine,oral contraceptives,premenopausal women,premenopause,migraine with aura,stroke,OCs,estrogen,headache,Anne H. Calhoun MD
Sections
Expert Commentary
Author(s)
Anne H. Calhoun, MD
Author(s)
Anne H. Calhoun, MD
Author and Disclosure Information

Dr. Calhoun is cofounder of the Carolina Headache Institute and Professor, Departments of Psychiatry and Anesthesiology, University of North Carolina, Chapel Hill.

Dr. Calhoun reports receiving research support from ElectroCore and GlaxoSmithKline, serving as a speaker for Nautilus Neurosciences and Zogenix, and consulting to Allergan, Nautilus, and Zogenix.

Author and Disclosure Information

Dr. Calhoun is cofounder of the Carolina Headache Institute and Professor, Departments of Psychiatry and Anesthesiology, University of North Carolina, Chapel Hill.

Dr. Calhoun reports receiving research support from ElectroCore and GlaxoSmithKline, serving as a speaker for Nautilus Neurosciences and Zogenix, and consulting to Allergan, Nautilus, and Zogenix.

Article PDF
Calhoun_Audio_transcript_Part1.pdf
Article PDF
Calhoun_Audio_transcript_Part1.pdf
Related Articles
Your postmenopausal patient reports a history of migraine
The gynecologist’s role in managing menstrual migraine
How to choose a contraceptive for a patient who has headaches

Part 1 Data dissection

  • Migraine versus migraine with aura versus tension headache
  • Baseline risk of stroke in patients with migraine
  • What does the literature suggest about the risk of stroke associated with combination oral contraceptives (OCs) in women with migraine?
  • What have been the objections in the past to OC use in women with migraine?

Part 2 Successful interventions for avoiding menstrual headache

  • How might women with migraine benefit from OCs?
  • Estrogen dose: Does it make a difference in headache avoidance?
  • Is low dose or continuous OC use the best option for contraception in women with migraine?
  • Should an ObGyn consult with a headache specialist before prescribing combination OCs to women with migraine?

Download transcript for Part 1

Download transcript for Part 2

Part 1 Data dissection

  • Migraine versus migraine with aura versus tension headache
  • Baseline risk of stroke in patients with migraine
  • What does the literature suggest about the risk of stroke associated with combination oral contraceptives (OCs) in women with migraine?
  • What have been the objections in the past to OC use in women with migraine?

Part 2 Successful interventions for avoiding menstrual headache

  • How might women with migraine benefit from OCs?
  • Estrogen dose: Does it make a difference in headache avoidance?
  • Is low dose or continuous OC use the best option for contraception in women with migraine?
  • Should an ObGyn consult with a headache specialist before prescribing combination OCs to women with migraine?

Download transcript for Part 1

Download transcript for Part 2

Issue
OBG Management - 25(10)
Issue
OBG Management - 25(10)
Publications
MDedge ObGyn
OBG Management
Publications
MDedge ObGyn
OBG Management
Topics
Contraception
Article Type
Audio
Display Headline
Is it time to rethink the use of oral contraceptives in premenopausal women with migraine?
Display Headline
Is it time to rethink the use of oral contraceptives in premenopausal women with migraine?
Legacy Keywords
migraine,oral contraceptives,premenopausal women,premenopause,migraine with aura,stroke,OCs,estrogen,headache,Anne H. Calhoun MD
Legacy Keywords
migraine,oral contraceptives,premenopausal women,premenopause,migraine with aura,stroke,OCs,estrogen,headache,Anne H. Calhoun MD
Sections
Expert Commentary
Article Source

PURLs Copyright

Inside the Article

Teaser Media
Article PDF Media